The ACSL4 abundance (Figs. 5c and 5d) was boosted, but GPX4 level (Figs. 5c and 5e) was reduced in myocardial tissues after EE induction, while these effects were diminished after AF co-treatment in a dose-dependent mode. Here, GPX4 is linked to atrial fibrillation.